Delphi Management Inc. MA raised its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 89.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,878 shares of the medical equipment provider’s stock after purchasing an additional 20,231 shares during the quarter. Zimmer Biomet Holdings comprises 3.0% of Delphi Management Inc. MA’s holdings, making the stock its biggest position. Delphi Management Inc. MA’s holdings in Zimmer Biomet Holdings were worth $5,363,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the business. Enterprise Financial Services Corp increased its stake in Zimmer Biomet Holdings by 0.3% during the 2nd quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock valued at $340,000 after purchasing an additional 9 shares in the last quarter. Sandy Spring Bank increased its stake in Zimmer Biomet Holdings by 1.7% during the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after purchasing an additional 20 shares in the last quarter. Cleararc Capital Inc. increased its stake in Zimmer Biomet Holdings by 0.5% during the 1st quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after purchasing an additional 25 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in Zimmer Biomet Holdings by 3.9% during the 2nd quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock valued at $112,000 after purchasing an additional 33 shares in the last quarter. Finally, CWA Asset Management Group LLC increased its stake in Zimmer Biomet Holdings by 1.8% during the 2nd quarter. CWA Asset Management Group LLC now owns 1,952 shares of the medical equipment provider’s stock valued at $251,000 after purchasing an additional 34 shares in the last quarter. Institutional investors and hedge funds own 85.36% of the company’s stock.

Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) traded up 0.03% during mid-day trading on Wednesday, reaching $118.45. 309,789 shares of the company were exchanged. Zimmer Biomet Holdings, Inc. has a 12 month low of $95.63 and a 12 month high of $133.49. The stock has a 50 day moving average price of $115.42 and a 200-day moving average price of $120.40. The stock has a market capitalization of $23.95 billion, a P/E ratio of 33.75 and a beta of 1.19.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.10 by ($0.02). The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.95 billion. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The business’s revenue was up 1.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.02 earnings per share. Analysts predict that Zimmer Biomet Holdings, Inc. will post $8.23 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be given a $0.24 dividend. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 dividend on an annualized basis and a yield of 0.81%. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is 27.59%.

ZBH has been the topic of a number of recent analyst reports. Zacks Investment Research lowered shares of Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 8th. Morgan Stanley upped their price target on shares of Zimmer Biomet Holdings from $137.00 to $150.00 and gave the company an “overweight” rating in a research note on Monday, July 17th. Oppenheimer Holdings, Inc. set a $137.00 price target on shares of Zimmer Biomet Holdings and gave the company a “buy” rating in a research note on Monday, August 14th. BMO Capital Markets restated a “buy” rating and set a $136.00 price target on shares of Zimmer Biomet Holdings in a research note on Tuesday, July 11th. Finally, Canaccord Genuity restated a “buy” rating and set a $141.00 price target on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $136.55.

In related news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction on Monday, July 31st. The shares were sold at an average price of $121.74, for a total value of $2,067,875.64. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 1.07% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Delphi Management Inc. MA Buys 20,231 Shares of Zimmer Biomet Holdings, Inc. (ZBH)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/11/delphi-management-inc-ma-buys-20231-shares-of-zimmer-biomet-holdings-inc-zbh.html.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Stock Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related stocks with our FREE daily email newsletter.